Related Experiment Videos
[Acute liver failure following tetrabamate]
Schweizerische Medizinische Wochenschrift
|May 13, 1995
Summary
Tetrabamate, used for alcohol withdrawal, can cause acute liver failure. This rare but severe side effect suggests avoiding tetrabamate for managing ethanol withdrawal symptoms.
Area of Science:
- Hepatology
- Pharmacology
- Toxicology
Background:
- Tetrabamate, a combination of phenobarbital, difebarbamate, and febarbamate, is prescribed for managing ethanol withdrawal symptoms.
- While generally well-tolerated, rare instances of reversible hepatitis and asthenia have been documented.
Observation:
- A 28-year-old female presented with acute liver failure following tetrabamate treatment for alcohol withdrawal.
- Liver biopsy indicated drug-induced toxic injury with extensive panlobular necrosis, distinct from alcoholic hepatitis.
Findings:
- The patient's liver parameters normalized within three months with supportive care.
- This case highlights a potentially lethal adverse effect of tetrabamate.
Implications:
- Tetrabamate should be used with extreme caution, if at all, for treating ethanol withdrawal symptoms.
- Further investigation into the hepatotoxicity of tetrabamate is warranted.